Vaibhav Sahai

30PUBLICATIONS
267CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsElectronic and magnetic properties of condensed matter; superconductivityChemical and thermal processes in energy and combustion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 23, 2026
A phase 2 multicenter trial of rucaparib and nivolumab as maintenance therapy in patients with advanced biliary tract cancer: BilT-02.

|Jul 10, 2026
Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract Cancers.

|May 22, 2026
Clearing the bar: adding anti-VEGF therapy to chemoimmunotherapy for biliary tract cancer.

|Apr 28, 2026
Dual targeting of PI3Kγ and STING overcomes regulatory B cell- and myeloid cell-driven immune suppression in pancreatic cancer.

|Apr 14, 2026
Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial.

Devalingam Mahalingam, Rachna T Shroff, Benedito A Carneiro

|Feb 27, 2026
Mitochondrial targets in IDH1-mutated cholangiocarcinoma.

Camila Carvalho, Fulei Wuchu, Nicole Peterson

Pageof 5

Frequent Collaborators

5 joint publications

Valerie Gunchick

5 joint publications

Jiaqi Shi

4 joint publications

Timothy L Frankel

4 joint publications

Filip Bednar